Company Badge
USPTO Data Jan 1 1976 - Sep 22 2026
8 Patents
#19 in Utrecht
#747 in Netherlands
Merus B.v.
Forward Citations = 298
11 inventors:
Merus B.v.
CIPO Patents = 2
EPO Patents = 5
Trademarks = 2
Forward Citations = 298
Loading Chart...
Loading Chart...
11 inventors (with patents filed for the assignee):
Ton Logtenberg (8 out of 59 patents)
Linda Johanna Aleida Hendriks (3 out of 10 patents)
Abraham Bout (3 out of 55 patents)
4. Cornelis Adriaan De Kruif (3 out of 54 patents)
5. Hendricus Renerus Jacobus Mattheus Hoogenboom (2 out of 28 patents)
6. Patrick H C Van Berkel (2 out of 3 patents)
7. Ronald Hendrik Peter Brus (2 out of 6 patents)
8. Ronald Hendrik Brus (1 out of 3 patents)
9. Patricius H C Van Berkel (1 out of 2 patents)
10. Mark Throsby (50 patents)
11. Rui Daniel Pinto (9 patents)
12. Patricius Hendrikus Van Berkel (1 patent)
13. Cecilia Anna Wilhelmina Geuijen (15 patents)
14. Patrick Hendrikus Cornelis Van Berkel (1 patent)
15. Hendricus Renerus Hoogenboom (0 patent)
8 patents:
Merus B.V. is a clinical-stage immuno-oncology company developing innovative full-length bispecific antibody therapeutics, referred to as Biclonics. Our lead product candidate, zenocutuzumab, is currently being evaluated in a Phase 1/2 clinical trial for various types of solid tumors. Merus' unique Biclonics platform allows for the precise targeting of multiple pathways to enhance tumor cell killing and potentially overcome treatment resistance.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
2 patents (CIPO):
Please report any incorrect information to [email protected]
5 patents (EPO):
Please report any incorrect information to [email protected]